Although it’s estimated that roughly 20% of patients with herpes simplex virus (HSV) keratitis will develop herpes stromal keratitis (HSK), I’d estimate 50% of HSV patients referred to our cornea clinic from ODs have HSK. This suggests we are more comfortable identifying and treating dendritic keratitis than we are with HSK. And it’s not surprising, given ...
Their presence could play an important role in diagnosing and treating herpetic disease.
Learning to recognize the processes that govern corneal health and function will allow you to gain a deeper understanding of pathologies and their treatments.
The human microbiome supports our existence, but it also serves as the source of infection. Resistance is on the rise, and clinicians have to prescribe carefully.
How should one respond when immune deficiency disrupts the corneal healing response?
Treating with antibacterial drugs can be tempting when presented with an acute infection. First make sure the agent matches the organism.
How do you handle a complex bacterial complication from a simple LASIK procedure?
Using a structured approach to determine which factors impede healing will lead to success with these often challenging scenarios.
The rise of an advanced form poses serious risks to patients. Here's how to get it under control—in the cornea and in the clinic.
Collagen crosslinking offers clinicians the potential to forever alter the impact of keratoconus on our patients.